HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 4, 1999, Pages 35-38

  Howell, W M ^a   Standring, P ^a   Warner, J A ^a   Warner, J O ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Atopy; HLA; sIgE

Indexed keywords

ALLERGEN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; IMMUNOGLOBULIN E;

ALLERGIC ASTHMA; ANTIGEN EXPRESSION; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; PEDIGREE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ALLERGENS; ASTHMA; GENES, MHC CLASS II; GENOTYPE; HLA-DR ANTIGENS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; PEDIGREE;

EID: 0033407391     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Thorsby E. HLA associated diseases. Hum Immunol 1997; 53:1-11.
2. Carballido JM, Faith A, Carballidoperrig N, Blaser K. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 1997; 27:515-21.
3. Howell WM, Holgale ST. Human leukocyte antigen genes and allergic disease. In: Monographs in Allergy, 33: Hall IP eds, Genetics of Asthma and Atopy. Karger, Basel, 1996: 53-70.
4. The Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nature Genet 1997; 15:389-92.
5. Caraballo L, Marrugo J, Jimenez S, Angelini G, Ferrara GB. Frequency of DPB1 *0401 is significantly decreased in patients with allergic asthma in a Mulatto population. Hum Immunol 1991; 32:157-61.
6. Aron Y, Swierczewski E, Lockhart A. HLA class II haplotype in atopic and non-atopic control subjects. Clin Exp Allergy 1995; 25 (Suppl. 2):65-7.
7. Kleine-Tebbe J, Eickholt M, Gatjen M, Brunnee T, O'Connor A, Kunkel G. A comparison between Magic Lite and CAP system: two automated specific IgE antibody assays. Clin Exp Allergy 1992; 22:475-84.
8. Howell WM, Leung ST, Jones DB, et al. HLA-DRB-DQA and -DQB polymorphism in celiac disease and enteropathy-associated T cell lymphoma: common features and additional risk factors for malignancy. Hum Immunol 1995; 43:29-37.
9. Standring P. Class II human leukocyte antigen gene polymorphisms, cell surface expression and immunoglobulin E mediated disease. PhD Thesis, University of Southampton, 1998.
10. Blumenthal M, Marcus-Bagley D, Awdeh Z, Johnson B, Yunis EJ, Alper CA. HLA-DR, 2 [HLA-B, 7 SC, 31 DR, 2] and [HLA, -B, 8 SC, 01 DR, 3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy. J Immunol 1992; 148:411-6.
11. Marsh DG, Blumenthal MN, Ishikawa T, Ruffilli A, Sparholt S, Freidhoff LR. HLA and specific immune responsiveness to allergens. In: Tsuji K, Aizawa M, Sasazuki T eds, HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol 1. Oxford Science Publications, 1992: 765-71.
12. Young RP, Dekker JW, Wordsworth BP, et al. H1A-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24:431-9.
13. Holloway JW, Doull I, Begishvili B, Beasley R, Holgate ST, Howell WM. Lack of evidence for a significant association between HLA-DR-DQ and -DP genotypes and atopy in families with HDM allergy. Clin Exp Allergy 1996; 26:1142-9.
14. Hori T, Kamikawaji A, Kimura A, et al. Japanese cedar pollinosis and HLA-DP5. Tissue Antigens 1996; 47:485-91.
15. Howell WM, Turner SJ, Hourihane JOB, Dean TP, Warner JO. HLA class II DRB1, DQB1 and DPB1 genotypic associations with peanut allergy: evidence from a family-based and case-control study. Clin Exp Allergy 1998; 28:156-62.
16. Vincent R, Louis P, Gongora C, Papa I, Clot J, Eliaou J. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J Immunol 1996; 156:603-10.